4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-053030
VP, Chief Accounting Officer gave up 15,603 shares (to pay taxes)
- VP, Chief Accounting Officer acquired 45,115 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Peraza Lisa VP, Chief Accounting Officer | 2023-07-25 | Option exercise | +42,631 | 67,941 | D | ||
| Peraza Lisa VP, Chief Accounting Officer | 2023-07-25 | Shares withheld for taxes | −14,743 | $1.51 | $22,262 | 53,198 | D |
| Peraza Lisa VP, Chief Accounting Officer | 2023-10-13 | Option exercise | +552 | 53,750 | D | ||
| Peraza Lisa VP, Chief Accounting Officer | 2023-10-13 | Option exercise | +1,932 | 55,682 | D | ||
| Peraza Lisa VP, Chief Accounting Officer | 2023-10-13 | Shares withheld for taxes | −860 | $0.72 | $619 | 54,822 | D |
| Derivatives | |||||||
| Peraza Lisa VP, Chief Accounting Officer | 2023-07-25 | Option exercise · Performance Stock Units | −42,631 | 0 | D | ||
| Peraza Lisa VP, Chief Accounting Officer | 2023-10-13 | Option exercise · Restricted Stock Units | −552 | 2,208 | D | ||
| Peraza Lisa VP, Chief Accounting Officer | 2023-10-13 | Option exercise · Restricted Stock Units | −1,932 | 7,964 | D | ||
Loading xslF345X05/doc4.xml…